Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing

Increasing environmental distress is associated with a growing asthma incidence; no treatments are available but montelukast (MTK)—an antagonist of the cysteinyl leukotrienes receptor 1—is widely used in the management of symptoms among adults and children. Recently, new molecular targets have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques, Cátia F., Marques, Maria Matilde, Justino, Gonçalo C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505853/
https://www.ncbi.nlm.nih.gov/pubmed/36145259
http://dx.doi.org/10.3390/ph15091039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505853/
https://www.ncbi.nlm.nih.gov/pubmed/36145259
http://dx.doi.org/10.3390/ph15091039

Ejemplares similares